Results 241 to 250 of about 482,699 (357)
A new era of cancer immunotherapy: vaccines and miRNAs. [PDF]
Sareen G+4 more
europepmc +1 more source
This study provides proof‐of‐concept evidence showing that through direct killing, antigen presentation, and competitively binding to BTN3A1, Vγ9Vδ2 T cells amplified from cervical cancer (CC) patients can synergize with αβ T cells to exert anti‐CC function both in vitro and in vivo.
Min Wu+21 more
wiley +1 more source
Cancer immunotherapy by antisense suppression of Ii protein in MHC-class-II-positive tumor cells
Gang Qiu+3 more
openalex +2 more sources
Recent advances in biomimetic nanodelivery systems for cancer Immunotherapy. [PDF]
Yang J, Li X, Li T, Mei J, Chen Y.
europepmc +1 more source
Combining immunotherapy with radiation therapy in thoracic oncology [PDF]
Badiyan, Shahed N+9 more
core +1 more source
An unprecedented high‐resolution spatial atlas of the E. multilocularis infection foci is obtained, revealing the dynamic functions of neutrophils, Spp1+ macrophages, and fibroblasts during disease progression. The transition of parasite control strategy from “active killing” to “negative segregation” by the host may provide instructive insights into ...
Zhihua Ou+35 more
wiley +1 more source
Update on the Role of Immunotherapy in the Management of Kidney Cancer
Gabriel P. Haas, Gilda G. Hillman
openalex +1 more source
Intratumoral injection of adenoviral vectors encoding tumor-targeted immunoconjugates for cancer immunotherapy [PDF]
Zhiwei Hu, Alan Garen
openalex +1 more source
Current Status of Breast Cancer Immunotherapy and Prognosis-Related Markers. [PDF]
Xu Y, Zhang B, Wu H, Wu Y.
europepmc +1 more source
The therapeutic potential of ApoVs derived from stem cells from human exfoliated deciduous teeth (SHED‐ApoVs) in the treatment of CD8+ T cell‐mediated hypersensitivity reactions is noteworthy. SHED‐ApoVs are capable of fusing with the plasma membrane of CD8+ T cells, which subsequently triggers a series of events characterized by calcium overload ...
Anqi Liu+13 more
wiley +1 more source